Reata Pharmaceuticals, Inc.

RETA · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$42,312$590,258$818,150$664,324
Short-Term Investments$345,202$0$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$10,256$6,217$29,188$4,952
Total Curr. Assets$397,770$596,475$847,338$669,276
Property Plant & Equip (Net)$116,437$138,381$4,912$2,996
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$284$160$5,348$10,148
Total NC Assets$116,721$138,541$10,260$13,144
Other Assets$0$0$0$0
Total Assets$514,491$735,016$857,598$682,420
Liabilities
Payables$18,706$13,505$4,790$1,908
Short-Term Debt$2,151$3,142$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$1,648$4,688$4,701
Other Curr. Liab.$38,103$35,699$109,724$185,405
Total Curr. Liab.$58,960$53,994$119,202$192,014
LT Debt$117,313$132,891$0$155,017
Deferred Rev, NC$0$0$4,688$9,389
Deferred Tax Liab, NC$0$0$0$62,161
Other NC Liab.$403,913$362,142$316,277$73,844
Total NC Liab.$521,226$495,033$320,965$233,549
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$580,186$549,027$440,167$425,563
Equity
Pref Stock$0$0$0$0
Common Stock$37$36$36$33
Retained Earnings-$1,567,532-$1,255,631-$958,245-$710,493
AOCI$0$0$0$0
Other Equity$1,501,800-$31-$31-$28
Total Equity-$65,695-$1,255,631-$958,245-$710,493
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$514,491-$706,604-$518,078-$284,930
Net Debt$77,152-$454,225-$818,150-$509,307